MusclePharm Corporation (OTCMKTS:MSLP) Files An 8-K Regulation FD Disclosure
ITEM 7.01
| REGULATION FD DISCLOSURE. |
On March 15, 2017, the Company issued a press release that
included the Companys open letter to shareholders. A copy of the
press release is attached to this report as Exhibit 99.1.
Item 9.01. Exhibits
| (d) | Exhibits |
| Exhibit No. | Description |
| 99.1 | Shareholder Letter dated March 15, 2017. |
About MusclePharm Corporation (OTCMKTS:MSLP)
MusclePharm Corporation is a performance lifestyle company. The Company develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. The Company’s portfolio of brands targets various types of fitness enthusiasts, including professional, combat sport, weight training, bodybuilding, running, basketball, soccer, cross fit, golf, tennis, volleyball and other active lifestyle activities. The MusclePharm Sport Series includes supplements that cover the needs of athletes, including their workout needs. MusclePharm Hybrid Series products include Assault, Amino1 and Combat Protein Powder. FitMiss products are designed and formulated for the active woman’s lifestyle utilizing ingredients that cover the range of busy women’s needs, including weight loss, multi-vitamins, protein shakes, detox, skin care and pre-workout energy mixes. MusclePharm Core products include BCAA 3:1:2, CLA Core and Fish Oil. MusclePharm Corporation (OTCMKTS:MSLP) Recent Trading Information
MusclePharm Corporation (OTCMKTS:MSLP) closed its last trading session 00.00 at 1.88 with 19,692 shares trading hands.